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When use 
goes beyond 
experimentation
Young people commonly experiment with substances such as alcohol and cannabis.1 Still, for the vast 
majority, experimentation does not lead to 
problematic use. In fact, at any given time, 
only an estimated 2.4% of Canadian youth 
use alcohol or drugs at a level that qualifies 
for a substance use disorder diagnosis — 
with alcohol and cannabis problems being 
the most common.2 Table 1 describes the 
diagnostic criteria used to identify substance 
use disorders in young people.3
o v e r v i e w
Understanding what puts young people at risk can help prevent substance use 
disorders or prevent them from getting worse.
Why focus on risk? 
Understanding what puts young people at risk can help prevent substance use disorders or prevent them 
from getting worse. To this end, researchers have studied a number of risk factors — by following large, 
representative groups of children over time. While these kinds of longitudinal surveys cannot establish 
causation, they can nevertheless point to risks that can be modified, in turn informing interventions. We 
identified four such child surveys from Canada, New Zealand and the United States, reporting on the risk 
factors they identified that may be amenable to change.
Table 1: Diagnostic Criteria for Substance Use Disorders 
a substance use disorder is defined as experiencing at least two of the following symptoms during a one-year period, 
leading to significant impairment.
•	 Using	the	substance	in	larger	amounts	or	over	a	longer	period	of	time	than	was	intended	
•	 Having	a	persistent	desire	to	use	less,	or	making	repeated	unsuccessful	attempts	to	use	less
•	 Spending	a	lot	of	time	obtaining	the	substance	or	using	it	or	recovering	from	its	effects	
•	 Having	cravings	for	the	substance
•	 Using	in	ways	that	result	in	failure	to	meet	major	obligations	at	home,	at	school	or	in	the	community
•	 Using	despite	having	social	problems	as	a	result
•	 Reducing	or	giving	up	important	social,	school	or	recreational	activities	because	of	substance	use	
•	 Using	the	substance	repeatedly	in	situations	that	are	dangerous
•	 Using	the	substance	despite	knowing	it	is	causing	or	worsening	physical	or	mental	health	problems
•	 Developing	tolerance,	e.g.,	needing	more	to	achieve	the	same	effect,	or	having	reduced	effects	with	the	same	
amounts
•	 Developing	withdrawal	symptoms	or	using	the	substance	to	relieve	or	avoid	these	symptoms
 source: adapted from the Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (2013).  
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Different countries, similar adversities
The Canadian survey followed nearly 4,000 residents of Quebec from kindergarten onwards. Researchers 
examined a range of substances in this study. It found two modifiable factors that predicted who would get 
a substance use disorder diagnosis in early adulthood, namely family adversity and child behaviour.4 Family 
adversity when children were in kindergarten was significantly associated with later cocaine use disorders. 
(Adversity included challenges such as low parental education or occupational status, young parental age and 
“non-intact family structure.”) The impact of family adversity was large, with affected children experiencing 
more than five times the odds of later being diagnosed with cocaine use disorder. The second modifiable factor 
was child behaviour. Children with symptoms of oppositional defiant disorder at any time between ages six 
and 12 were significantly more likely to develop cannabis and cocaine use disorders as young adults. The 
impact was large here as well, with affected children experiencing more than two times the odds of later being 
diagnosed with either of these disorders.4
Researchers in New Zealand identified similar modifiable risk factors for “persistent” substance use 
disorders after following more than 1,000 children from ages three to 38.5 To be deemed as having a 
“persistent” disorder, participants had to meet diagnostic criteria for substance dependence at multiple points 
during the study. Two kinds of childhood adversity were predictive — family socio-economic disadvantage 
(based on parental occupational levels over the first 15 years of the child’s life) and child maltreatment (at 
any time between ages three and 11). Maltreatment included maternal rejection, harsh discipline or physical 
abuse, two or more changes in primary caregiver, and/or sexual abuse. Children who experienced family 
socio-economic disadvantage had an 80% increase in risk for being diagnosed with a persistent substance 
use disorder, while those who experienced child maltreatment had a 62% increase in risk. This survey also 
identified one important risk factor that emerged in adolescence. Frequent drug and alcohol use in early 
adolescence and mid-adolescence increased the risk for later “persistent” substance use diagnoses by 276%.5
One of the two American studies, meanwhile, followed from birth more than 
1,000 Minnesotan children, all twins, to identify risk factors at age 17 that predicted 
alcohol use disorder by age 29.6 Once again, family adversity emerged as a risk factor — 
including family socio-economic disadvantage, negative parent-child relationships, and 
parental behaviour symptoms. Women who had experienced these forms of adversity had 
1.5 times the odds of being diagnosed with alcohol use disorder, while men had 1.6 times 
the odds. Beyond family adversity, serious behaviour problems in late adolescence also 
increased the likelihood for an alcohol use diagnosis, approximately doubling the odds. 
Having peers with behaviour problems was an added risk factor, leading to women 
having 2.1 times the odds and men having 1.4 times the odds of receiving an alcohol use 
diagnosis. Heavy alcohol and drug use at age 17 were other risk factors for an alcohol use 
disorder, with between 1.8 and 4.3 times the odds, depending on sex and substance type. Finally, depressive 
symptoms at age 17 predicted later alcohol use disorder, but only for females — who had 1.6 times the odds 
of receiving this diagnosis.6
The fourth study, also American, involved researchers following more than 1,400 children from North 
Carolina for up to 12 years, investigating how family income supplements might influence child outcomes.7 
The supplements were provided to Indigenous families, starting partway through the study, and were sufficient 
to move many families out of poverty — while allowing comparisons to families not receiving supplements. 
Increased family income was associated with significantly reduced odds of young people later receiving 
any substance use diagnosis, or receiving alcohol or cannabis diagnoses more specifically.7 For cannabis in 
overv iew
Children who 
experienced family 
socio-economic 
disadvantage had an 
80% increase in risk 
for being diagnosed 
with a persistent 
substance use 
disorder.
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particular, serious behaviour issues between ages nine and 16 were a modifiable risk factor for problematic use 
in early adulthood, independent of family income.8 Similarly, early use of tobacco, alcohol and illegal drugs 
each predicted problematic cannabis use in early adulthood.8
Addressing avoidable early adversities
These four surveys point to ways of preventing young people from developing substance 
use disorders — by addressing avoidable early adversities such as family socio-economic 
disadvantage and child maltreatment. The North Carolina study shows how socio-economic 
disadvantage may be addressed by providing families with income supplements that lift 
them out of poverty.7 Parenting programs can also avert childhood maltreatment,  
as highlighted in our Spring 2009 issue. 
Some of the secondary effects of childhood adversities can also be addressed. Child 
behaviour problems can be prevented with parenting programs, as highlighted in our Fall 
2015 issue. Youth depression can also be prevented with Cognitive-Behavioural Therapy, 
as highlighted in our Summer 2017 issue. And substance use in the teen years can be reduced with universal 
school prevention programs, as highlighted in our Winter 2018 issue. 
Yet even if effective early interventions were made widely available, some young people would still go on to 
use substances in harmful ways. Effective treatments therefore need to be made readily available as well. In the 
Review article that follows, we identify recent research evidence on these treatments.
overv iew
What about Indigenous youth?
to learn more about indigenous youth in Canada, the First nations information Governance Centre, a non-profit organization operating under a mandate from the assembly of First nations, conducted a survey. the survey 
examined multiple indicators of health and well-being for indigenous people living on-reserve and in northern 
communities.9 as part of this work, nearly 5,000 youth (aged 12 to 17) from 253 communities across the country 
were asked about their experiences with substance use. More than 70% of youth reported consuming no alcohol 
or street drugs in the past year. among the street drugs, cannabis was the most common choice, used by 27.2% 
(compared with 2.3% for hallucinogens, 2% for cocaine, 1.1% for ecstasy, and less than 1% for stimulants and 
inhalants).
these findings parallel those from an earlier survey conducted in BC by the First nations health authority.10 For 
this survey, researchers canvassed 437 youth from 36 on-reserve and other communities across the province. More 
than 60% of youth (aged 12 to 17) reported consuming no alcohol in the past year. similarly, nearly 70% reported 
using no street drugs in the past year.
despite the legacies of colonialism and racism, including residential schools and ongoing socio-economic 
disadvantage for many, the findings from these two surveys suggest resilience and strength in First nations youth. 
these surveys also suggest that the percentage of indigenous youth who are struggling with substance use is limited. 
to meet the needs of these young people, the First nations information Governance Centre calls for interventions 
that encompass a comprehensive model involving physical, emotional, spiritual and mental well-being.9 to promote 
well-being for young people, the authors also emphasize the importance of strong connections with communities 
and with families.9
Serious behaviour 
problems in late 
adolescence also 
increased the 
likelihood for an 
alcohol use diagnosis, 
approximately 
doubling the odds.
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Effective treatments for youth substance 
use disorders
Youth who develop substance use disorders need to receive effective treatments. And 
to ensure good care for these young 
people, practitioners and policy-
makers need to know what works. 
To identify effective treatments, we 
therefore conducted a systematic 
review, updating and building 
on findings presented in our 
Summer 2010 issue. 
Building on approaches 
that work 
Our Summer 2010 issue identified 
three effective treatment categories: 
Cognitive-Behavioural Therapy 
(CBT), Ecological Family Therapies, 
and Motivational Interventions.11 
•	 CBT	involved	teaching	youth	
to modify their thinking and behaviour. Techniques included identifying triggers for substance use and 
engaging in activities that discouraged use, for example, spending time with peers who did not use. 
•	 Ecological	Family	Therapies	included	different	specific	therapies	that	targeted	substance	use	in	the	context	
of relationships with families, schools and peers. These interventions included Ecologically Based Family 
Therapy, Multidimensional Family Therapy and Multisystemic Therapy (MST). 
•	 Motivational	Interventions	involved	brief	therapies	aimed	at	building	on	the	youth’s	own	motivation	to	
reduce their substance use, helping them to then change their behaviour. The specific therapies included 
Brief Motivational Intervention and Motivational Enhancement Therapy.
Evaluating new evidence 
Building on this earlier review, we searched for new randomized controlled trials (RCTs) 
evaluating adolescent substance use interventions published in the past 10 years. We built 
quality assessment into our inclusion criteria to ensure that we reported only on the best 
available evidence. Specifically, studies had to use a control group, receiving either no 
treatment or treatment-as-usual, to rule out other factors that could account for benefits, 
such as the passage of time. We also accepted head-to-head trials — designed to directly 
compare the effectiveness of two or more treatments — provided at least one of the 
treatments had already been established as effective. Treatments that could be classified as 
CBT, Ecological Family Therapies and/or Motivational Interventions were all included. 
(Please see our Methods for further details on our search strategy and inclusion criteria.)
r e v i e w
CBT, Multidimensional Family Therapy and Motivational Interventions all have strong 
evidence of effectiveness.
There are many 
effective community-
based treatments 
for substance 
use disorders, so 
practitioners should 
choose one that 
most suits the young 
person.
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We retrieved and assessed 104 studies; of these, eight RCTs met our inclusion criteria. These RCTs 
evaluated nine different therapies, or combinations of therapies, all delivered in outpatient clinics or homes. 
None evaluated interventions delivered in residential treatment centres. Youth in these trials were recruited 
from various settings, including the youth justice system in some cases. Two RCTs tested interventions using  
a control group, and the other six RCTs involved head-to-head comparisons. 
Treatment trials with control groups
Both RCTs that used control groups focused on cannabis. One RCT assessed Adolescent Cannabis Check-Up, 
which used a combination of CBT and Motivational Enhancement Therapy techniques — compared with 
no-treatment controls.12 The other RCT assessed Multidimensional Family Therapy, compared with control 
participants who received treatment-as-usual.13 Table 2 provides more information on these two interventions 
and their associated RCTs.
rev iew
Providing community-
based programs to all 
youth in need early 
on can also prevent 
the need for more 
costly and disruptive 
residential care.
 
Table 2: Treatment Trials with Control Groups 
Child ages 
(Country)
14–19 years 
(australia)
3–18 years 
(5 european 
countries)
Sample  
size
40
 
450 
Treatment 
adolescent Cannabis 
Check-Up12
Multidimensional Family 
therapy13
Approach  
2 youth sessions over 2 weeks
 
52 youth + parent + family sessions over  
6 months 
  
Substance  
targeted 
Cannabis
 
Cannabis
 
Head-to-head treatment trials
The remaining interventions were evaluated in six head-to-head trials, including Case Management, CBT, 
CBT plus Motivational Interviewing, Community Reinforcement, Ecologically Based Family Therapy, 
Motivational Enhancement Therapy, Motivational Interviewing and Multidimensional Family Therapy. 
These treatments are described below (with the exception of CBT, which was described previously; please see 
page 6). 
Case Management involved paraprofessionals linking youth to community resources, including 
housing and health care, using a strengths-based approach; this was the only intervention that was not 
delivered by practitioners.14 Community Reinforcement used behavioural techniques such as identifying 
triggers, consequences and alternatives to substance use; the intervention also taught 
communication and problem-solving skills.14–15 Ecologically Based Family Therapy 
focused on changing family interactions that were inadvertently supporting problematic 
substance use.15 Motivational Interviewing (both alone and adjunctively with CBT) and 
Motivational Enhancement Therapy involved practitioners expressing empathy, while 
supporting youth to have self-efficacy and to increase their motivation and capability 
to reduce their using.14–16 (We classified both therapies as falling into the category of 
Motivational Interventions.)14 Multidimensional Family Therapy, meanwhile, entailed 
teaching skills such as relapse prevention, family communication, problem-solving and 
parenting.17
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For these six head-to-head trials, detailed in Table 3, five did not limit involvement by type of substance 
used. Only one — Multidimensional Family Therapy II compared to CBT — focused exclusively on 
cannabis.18 Notably, youth involved in these head-to-head trials faced challenges that went well beyond 
substances. For example, many were involved in the justice system and some had experienced unstable 
housing.14–19 Table 3 provides more information on these interventions and their associated RCTs.
rev iew
Outcomes for treatment trials with control groups
Both interventions assessed in these trials revealed benefits. Adolescent Cannabis Check-Up resulted in 
teens reporting significantly fewer cannabis use disorder symptoms at three-month 
follow-up. This outcome was also clinically meaningful as demonstrated by its moderate 
effect size (Cohen’s d = 0.70). Treatment youth also reported fewer days of cannabis 
use and less overall use, with moderate and small effect sizes, respectively (d = 0.71 and 
d = 0.22).12
Similarly, Multidimensional Family Therapy resulted in teens reporting significantly 
fewer cannabis use disorder symptoms at six-month follow-up.13 The effect size for this 
outcome was large (d = 1.66). Still, there were no differences in diagnoses or days of cannabis use between 
intervention and control groups.13 Table 4 details the outcomes for these two RCTs.
 
Table 3: Head-to-Head Treatment Trials  
Treatment 
Multidimensional Family 
therapy i17 
Cognitive Behavioural 
therapy (CBt)
Multidimensional Family 
therapy ii18
CBt
Multidimensional Family 
therapy iii19
CBt
Multidimensional Family 
therapy iV16
CBt + Motivational 
interviewing
Motivational interviewing15
Community reinforcement
ecologically Based Family 
therapy
Motivational enhancement 
therapy14
Community reinforcement
Case Management
Approach  
17–26 family + 17–26 youth + parent 
sessions over 4–6 months
15–24 youth + 2 family sessions over  
4–6 months 
43–52 youth, parent + family sessions over 
5–6 months*
21–26 youth sessions + 5–6 parent sessions 
over 5–6 months 
24–32 youth, parent + family sessions over 
3–4 months 
24–32 group youth sessions over 3–4 months 
34–52 youth, parent + family sessions over 
4–6 months
52–78 group youth sessions over 4–6 months 
4 youth sessions over 6 months
14 youth sessions over 6 months 
14 family sessions over 6 months 
2 youth sessions over 6 months 
12 youth sessions over 6 months
12 youth sessions over 6 months
Sample  
size
224
109
83
112 
179
270 
 
Child ages 
(Country)
12–17 years
(United 
states)
13–18 years 
(the 
netherlands) 
11–15 years 
(United 
states) 
13–18 years 
(United 
states) 
12–17 years 
(United 
states) 
14–20 years 
(United 
states) 
Substances  
targeted 
all
 
Cannabis 
all 
all  
all
all 
* Practitioners also provided sessions or had contact with school, court and other (unspecified) individuals.  
Adolescence is the 
optimal time to 
intervene to avert 
far more serious 
problems later on.
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Outcomes for head-to-head treatment trials
Among the six head-to-head evaluations, two compared Multidimensional Family Therapy and individual 
CBT. In the first of these trials, both interventions showed statistically significant benefits on two of five 
substance use outcomes at one-year follow-up. These benefits were decreases in substance use severity overall 
and decreases in frequency of cannabis use.17 Compared with CBT, Multidimensional Family Therapy also 
led to reduced severity of problematic substance use and to fewer days of using substances other than alcohol 
or cannabis, with moderate and small effect sizes (d = 0.59 and d = 0.32, respectively). As well, significantly 
more Multidimensional Family Therapy youth reported abstaining from using all substances during one-year 
follow-up, compared with those receiving CBT. 
In the second RCT comparing Multidimensional Family Therapy to individual CBT, both interventions 
produced statistically significant reductions in the number of days of cannabis use and in the quantity of 
cannabis used by six-month follow-up.18 However, there were no differences between the two treatments on 
these two measures, or on measures of treatment response or treatment recovery. (The 
authors defined “treatment response” as having at least 30% fewer cannabis-using days in 
the 90 days preceding final follow-up compared to baseline, with no substantial increase in 
other substances used. They defined “treatment recovery” as living in the community and 
abstaining from cannabis and other substances, but still drinking up to 5 or fewer servings 
of alcohol a day, despite this quantity of alcohol being problematic.) At six-month follow-up, 41.8% of 
Multidimensional Family Therapy youth and 44.4% of CBT youth achieved treatment response, while 14.5% 
and 5.6%, respectively, achieved treatment recovery.18
In the third RCT, Multidimensional Family Therapy was compared to group CBT. Youth in both 
treatments reported significantly fewer problems due to their substance use from the start of the treatments 
to final follow-up of just over eight months.19 Similarly, youth in both interventions reported increasing 
abstinence from all substances over the course of treatment. However, Multidimensional Family Therapy 
youth reported significantly fewer problems as a result of their substance use than CBT youth, with a large 
effect size (d = 1.36). As well, more Multidimensional Family Therapy youth reported being abstinent than 
CBT youth, with over double the odds of abstaining (odds ratio = 2.20). Multidimensional Family Therapy 
youth also reported fewer overall days of substance use than CBT youth, with a large effect size (d = 0.77).19
The fourth and final RCT assessing Multidimensional Family Therapy compared it to a group using a 
combination of CBT and Motivational Interviewing. For both interventions, youth reported fewer substance 
use problems by 18-month follow-up, with no significant difference between the two.16 Similarly, for both 
interventions, youth reported using fewer substances overall at 18-month follow-up, also with no significant 
difference between the two.16 Table 5 details all substance use outcomes for the head-to-head comparisons of 
Multidimensional Family Therapy and CBT.
Table 4: Outcomes for Treatment Trials with Control Groups
 statistically significant reductions for treatment group over comparison group.
 no significant difference between treatment and comparison group.
Treatment
adolescent Cannabis Check-Up12 
 
Multidimensional Family therapy13
Follow-up 
3 months 
 
6 months
Child outcomes
 symptoms of cannabis use disorder
 days of cannabis use
 Quantity of cannabis use
 symptoms of cannabis use disorder
  Cannabis use disorder diagnoses
  days of cannabis use
 
Youth substance 
misuse is a problem 
we can address.
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Table 5: Outcomes for Head-to-Head Treatments
/	statistically significant benefits for given treatments over time or for given treatment over alternative treatment.
  no statistically significant benefits for given treatments.
Treatment
Multidimensional Family Therapy vs.  
Cognitive Behavioural Therapy  
(CBT) I17 
 
 
 
 
 
Multidimensional Family Therapy vs.  
CBT II18 
 
 
 
Multidimensional Family Therapy vs.  
CBT III19
 
 
 
 
 
Multidimensional Family Therapy vs.  
CBT + Motivational Interviewing16
 
Motivational Interviewing vs. 
Community Reinforcement vs. 
Ecologically-Based Family Therapy 15
Motivational Enhancement Therapy vs. 
Community Reinforcement vs.  
Case Management14
     
Follow-up 
1 year
 
 
 
 
 
 
 
6 months
 
 
 
 
8¼ months 
 
 
 
 
 
 
1½ years
 
 
1½ years
 
 
6 months
Child outcomes
Both treatments resulted in
 substance use problem severity
 days of cannabis use
 days of alcohol use
Multidimensional Family Therapy outperformed CBT in
 substance use problem severity
 days of substance use (other than alcohol + cannabis) 
 substance use abstinence
Both treatments resulted in 
 days of cannabis use
 Quantity of cannabis use 
 treatment response
 treatment recovery
Both treatments resulted in 
 number of substance use problems
 substance use abstinence
Multidimensional Family Therapy outperformed CBT in
 number of substance use problems
 days of substance use
 substance use abstinence
Both treatments resulted in
 number of substance use problems
 number of substances used 
All treatments resulted in
 days of substance use
 
All treatments resulted in
 days of alcohol use
 days of drug use
 
The remaining two of six head-to-head evaluations each compared three different treatments, as shown in 
Table 5, above. In the RCT evaluating Motivational Interviewing, Community Reinforcement and Ecologically 
Based Family Therapy, all three treatments led to statistically significant declines in days of substance use over 
18-month follow-up.15 There were no differences for this outcome across the three treatments.15
Similarly, in the RCT comparing Motivational Enhancement Therapy, Community Reinforcement and 
Case Management, all three treatments led to statistically significant declines in days of alcohol and drug use 
over six-month follow-up, as shown in Table 5.14 Once again, there were no differences on either outcome 
across the three treatments.14
Implications for practice and policy
For treating youth substance misuse, findings from this and our previous reviews show that there are many 
effective interventions. CBT, Multidimensional Family Therapy and Motivational Interventions all have strong 
evidence of effectiveness, with positive outcomes from multiple RCTs. As well, Community Reinforcement, 
Ecologically Based Family Therapy, Adolescent Cannabis Check-Up, Case Management and Multisystemic 
Therapy were each successful in at least one RCT. Several recommendations emerge for practice and policy:
•  Choose the treatment that fits the youth. There are many effective community-based treatments for 
substance use disorders, so practitioners should choose one that most suits the young person. For example, 
Multidimensional Family Therapy may be a particularly good fit where parents are able and willing to 
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engage. Alternatively, where youth want individual treatment or where parents cannot engage, CBT is a 
good option. And for youth who want briefer approaches, Motivational Interventions may be best. Young 
people should always have a voice in these choices.
•  Break down treatment barriers. Many teenagers who struggle with substance use have other mental 
health challenges, including with behaviour. So when a young person wants help with substance use, 
practitioners should be prepared to address other challenges as well. Providing treatments for everything in 
one venue is also far better than making youth attend different practitioners at different locations. Waitlists 
create a further barrier for young people, so these should be avoided.
•  Give practitioners the tools to help. Practitioners need the appropriate education and experience to 
provide youth with effective treatments for substance use disorders. CBT is a good place to start. Many 
practitioners already have considerable experience with CBT. For those who do not, short courses for 
mental health professionals are readily available. In contrast, training in other therapies can be far more 
costly. For example, the cost of certifying four practitioners (the minimum required) in Multidimensional 
Family Therapy is over $30,000 for the first year and approximately $10,000 per year after that, plus 
trainer travel costs.20 Policy-makers can help by supporting publicly funded mental health teams to acquire 
the training they need.
•  Help all youth in need early on. As with other mental health problems, all young people who struggle 
with substance misuse need access to effective treatments, as well as to effective prevention programs, as 
discussed in our previous issue. This review has provided examples of effective treatments, all of which 
could be adapted and provided in Canada, preferably with concomitant local evaluations. Providing 
community-based programs to all youth in need early on can also prevent the need for more costly and 
disruptive residential care, while alleviating burdens caused by substance misuse.
Substance use disorders take a tremendous toll. These disorders also typically become entrenched if 
effective interventions are not provided early in life. Yet we know how to treat and prevent these disorders in 
young people. In fact, adolescence is the optimal time to intervene to avert far more serious problems later on. 
Here we have outlined several treatments that have been tested in multiple RCTs and that could be feasibly 
offered to young people in BC. These interventions should be made readily available to all youth in need, 
in youth-friendly and youth-empowering formats and settings. Youth substance misuse is a problem we can 
address. Effective efforts to do so in turn can reduce much needless distress and avoidable harm associated 
with substance misuse in adulthood.    
Addressing the opioid emergency
BC’s Provincial health Officer declared a public health emergency in response to overdose deaths from opioids.21 as part of this 
response, some youth with opioid use disorders are being prescribed 
methadone or buprenorphine/naloxone (BUP/nal; brand name 
suboxone). Unfortunately, no evaluations of these treatments met 
the inclusion criteria for our review. We decided to present the best 
available evidence pertaining to youth. We identified one randomized 
controlled trial (rCt) evaluating BUP/nal.22
this rCt included 152 young people between ages 15 and 21 
who were attending community clinics in the Us. Participants were 
randomly assigned to receive either 12 weeks of BUP/nal (up to 24 
mg/day for nine weeks, then tapered and discontinued by  
12 weeks) or two weeks of BUP/nal (up to 14 mg/day, then tapered 
and discontinued by two weeks). Youth in both groups also received 
weekly individual and group counselling for 12 weeks.22
Over the course of the three- to nine-month follow-up, young 
people who received 12 weeks of higher-dose BUP/nal had 
significantly fewer opioid-positive urine tests than comparison  
youth.22 as well, at nine-month follow-up, those who received
12 weeks of BUP/nal reported significantly less opioid use in the past 
month	than	those	who	received	the	medication	for	just	two	weeks.	
the two groups, however, did not significantly differ regarding self-
reported	alcohol,	marijuana,	cocaine	and	injection	drug	use	(types	not	
specified) over the follow-up period. although there were no reported 
serious adverse events attributed to BUP/nal, the authors noted that 
the sample size was too small to draw conclusions about the drug’s 
safety.22 still, electrocardiogram data found that the short-term use of 
BUP/nal was not associated with problematic changes in heart rate.23
researchers also conducted a cost analysis, including direct 
treatment costs as well as costs associated with other health 
services, crime, education and workforce participation.24 the 12-week 
intervention cost more per participant than the two-week version.24 
Still,	given	significantly	improved	quality-adjusted	life-years	associated	
with the longer BUP/nal treatment, the authors concluded that there 
was evidence that longer treatment provided value.24 (BUP/nal is 
covered under BC PharmaCare’s Psychiatric Medications Plan.)21
these evaluation results provide preliminary evidence that BUP/
nal is an effective treatment for youth with opioid use disorder. 
however, further research is needed on BUP/nal’s long-term efficacy 
and safety for this population. 
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We use systematic review (SR) methods adapted from the Cochrane Collaboration and Evidence-Based Mental Health. We build quality assessment into our inclusion criteria to ensure that we report on the best available evidence — requiring that intervention studies use randomized 
controlled trial (RCT) methods and also meet additional quality indicators. For this review, we searched for 
RCTs on treating substance use disorders in young people. Table 6 outlines our database search strategy.
To identify additional RCTs, we also hand-searched reference lists from a published SR on outpatient 
behavioural treatments,25 and from previous Children’s Health Policy Centre publications. Using this 
approach, we identified 104 studies. Two team members then independently assessed each study, applying the 
inclusion criteria outlined in Table 7. 
Eight RCTs met all the inclusion criteria. Figure 1, on the following page, shows a flow diagram of our 
search process, adapted from PRISMA. Data from these studies were then extracted, summarized and verified 
by two or more team members. Throughout our process, any differences between team members were resolved 
by consensus.   
For more information on our research methods, please contact
Jen Barican, chpc_quarterly@sfu.ca 
Children’s Health Policy Centre, Faculty of Health Sciences  
Simon Fraser University, Room 2435, 515 West Hastings St. Vancouver, BC  V6B 5K3 
m e t h o d s
•	 Campbell,	Cochrane,	CINAHL,	ERIC,	Medline	and	PsycINFO
•	 Substance-related	disorder,	substance	abuse,	substance	dependence,	substance	use,	
drug abuse, drug dependence or addiction and treatment, therapy or intervention  
•	 Peer-reviewed	articles	published	in	English	between	2007	and	2017
•	 Pertaining	to	children	aged	18	years	or	younger
•	 Systematic	review,	meta-analysis	or	RCT	methods	used
Table 6: Search Strategy
Sources
 
Search Terms
Limits
Table 7: Inclusion Criteria for RCTs  
•	 Participants	were	randomly	assigned	to	intervention	and	control	groups	(i.e.,	no	intervention	or	
treatment-as-usual), or to different intervention groups (i.e., head-to-head trials)
•	 For	head-to-head	trials,	at	least	one	intervention	was	already	established	as	being	effective	according	
to the systematic review featured in our summer 2010 issue   
•	 Clear	descriptions	were	provided	of	participant	characteristics,	settings	and	interventions
•	 Interventions	aimed	to	treat	adolescent	substance	use	disorders
•	 Interventions	were	evaluated	in	settings	that	were	applicable	to	Canadian	policy	and	practice	
•	 At	study	outset,	most	participants	had	a	substance	use	disorder	diagnosis
•	 Studies	assessing	continuing	or	after-care	interventions	were	excluded	if	the	initial	treatment	was	not	
evaluated 
•	 Follow-up	was	three	months	or	more	(from	the	end	of	the	intervention)
•	 Attrition	rates	were	20%	or	less	at	follow-up	and/or	intention-to-treat	analysis	was	used
•	 Outcome	indicators	included	substance	use	disorder	diagnoses	or	symptoms,	assessed	at	follow-up	
•	 Reliability	and	validity	of	all	primary	outcome	measures	or	instruments	was	documented
•	 Levels	of	statistical	significance	were	reported	for	primary	outcome	measures
•	 Studies	were	excluded	where	authors	indicated	lack	of	statistical	power	for	assessing	primary	
outcomes
•	 For	medication	studies,	double-blinding	procedures	were	used
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methods
Records identified through database 
searching
(n = 3,117)
Records identified through 
hand-searching
(n = 13)
Records excluded after title screening 
(n = 2,283)
Abstracts excluded
(n = 700)
Full-text articles excluded  
(n = 96 studies [131 articles])
Total records screened 
(n = 3,130)
Abstracts screened for relevance
(n = 847)
Full-text articles assessed 
for eligibility
(n = 104 studies [147 articles])
Studies included in review
(n = 8 studies [16 articles])
Figure 1: Search Process for RCTs
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To best help children, practitioners and policy-makers need good evidence on whether or not a given intervention works. Randomized controlled trials (RCTs) are the gold standard for assessing if an intervention is effective. In RCTs, children are randomly assigned to the intervention group or to a 
comparison or control group. By randomizing participants — that is, giving every child an equal likelihood of 
being assigned to a given group — researchers can help ensure the only difference between the two groups is 
the intervention. This process provides confidence that any benefits are due to the intervention rather than to 
chance or other confounding factors.
Then, to determine whether the intervention actually provides benefits to children, researchers analyze key 
outcomes. If an outcome is found to be statistically significant, it helps provide certainty the intervention 
was effective rather than it appearing that way due to a random error. In the studies that we review, researchers 
set a value enabling at least 95% confidence that the observed results are real. Once an intervention has been 
found to have a statistically significant benefit, it is helpful to quantify the magnitude of difference it made, 
or its effect size. Beyond identifying that the intervention works, an effect size provides an indicator of how 
much of a clinically meaningful difference the intervention makes in children’s lives. Cohen’s d is the most 
commonly used measure of effect size. Values can range from 0 to 2. Standard interpretations are 0.2 = small 
effect; 0.5 = medium effect; 0.8 = large effect. Odds ratio is another frequently used measure of effect size. It 
indicates how many times greater or lesser the chances are of a given outcome occurring. For example, an odds 
ratio of 2.0 indicates that youth who received the intervention had twice the odds (e.g., of being abstinent 
from drugs).  
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